ロード中...
ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
BACKGROUND: CD133 and AXL have been described as cancer stem cell markers, and c-MYC as a key regulatory cellular mechanism in colorectal cancer (CRC). AIM: Evaluate the prognostic role of the biomarkers CD133, AXL and c-MYC and their association with clinicopathologic characteristics in colorectal...
保存先:
| 出版年: | Arq Bras Cir Dig |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Colégio Brasileiro de Cirurgia Digestiva
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983529/ https://ncbi.nlm.nih.gov/pubmed/33759958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0102-672020200004e1568 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|